John W. Devine, an attorney with particular skill and experience handling transactional and regulatory matters in the health care and life sciences industries, has joined the firm as of counsel in Philadelphia, Business and Finance Department Chair Brian M. Pinheiro announced today.

Before joining the firm, Mr. Devine was the Chief Legal Officer for PharmaCo Ventures and spent more than a decade in private practice. He has significant experience handling middle market mergers and acquisitions in the health care sector, and is ideally positioned to guide clients through challenges and opportunities arising from the Affordable Care Act.

While at PharmaCo Ventures, Mr. Devine helped develop and implement an ancillary pharmaceutical and laboratory services business. He also successfully promoted the company’s business model before state regulatory agencies.

“John is an exceptional lawyer with in-house perspective, experience on both the regulatory and transactional sides, and a deep understanding of the health care industry,” Mr. Pinheiro said. “Ballard Spahr’s Health Care Group handles sophisticated matters for top clients. John is a seamless fit and we’re delighted to have him at the firm.”

Outside the health care sector, Mr. Devine has represented clients both nationally and internationally in private equity transactions, venture capital investments, debt and equity financings, and commercial licensing transactions. That work has included foreign and domestic general corporate counseling, structuring and documenting limited liability companies, and advising life sciences companies on transactional as well as debt and equity financing matters.

Ballard Spahr’s health care attorneys advise on regulatory, compliance, and transactional matters as well as financing, benefits and compensation, and labor and employment issues. Our Life Sciences and Technology Group counsels businesses and institutions engaged in innovation, development, and commercialization activities. The firm’s more than 70 M&A/private equity attorneys represent buyers and sellers in deals that not only span the middle market but also include multibillion-dollar mergers and acquisitions.

“The next 10 years will bring challenges, but also tremendous opportunities for those in the health care industry with insight and a solid plan,” Mr. Devine said. “I look forward to working with my colleagues at Ballard Spahr to help clients navigate the obstacles and identify and capitalize on opportunity.”

Related Area